Renoprotective effects of dulaglutide in patients with T2DM and CKD
- PMID: 30171207
- DOI: 10.1038/s41581-018-0055-x
Renoprotective effects of dulaglutide in patients with T2DM and CKD
Comment on
-
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.Lancet Diabetes Endocrinol. 2018 Aug;6(8):605-617. doi: 10.1016/S2213-8587(18)30104-9. Epub 2018 Jun 14. Lancet Diabetes Endocrinol. 2018. PMID: 29910024 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
